Adaptive Immunity Contributes to the Progressive Pathology of Multiple Sclerosis: Implications for Clinical Development
Time: 3:45 pm
day: Day Two
Details:
• Progression Independent of Relapse Activity (PIRA) – what it is and why it matters.
• Meningeal aggregates in MS – stable, pathogenic, resistant to current therapies
• Imaging shows, for the first time, tissue injury associated with CNS compartmentalized progressive pathology of MS
